Nigeria

in page functions
[French]
Nigeria
Total population (2017) 191,835,907
Birth cohort (2017) 7,322,279
Surviving Infants (surviving to 1 year per year, 2017) 6,822,481
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 69/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 109/1000
World Bank Index, IDA (2015) 3.41
Gross Nation Income (per capita US$, 2015) 2,820
Co-financing group (2017) Accelerated transition
No. of districts/territories (2016) 774

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Nigeria

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2001 2002 2003 2004 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $775,357,253 $1,007,595,253 $732,130,326
Health system strengthening (HSS 1) $42,504,000 $42,504,000 $40,238,758 95%
Immunisation services support (ISS) $47,324,000 $47,324,000 $47,324,000 100%
Injection Safety Devices (NVS) $3,632,500 $6,609,500 $3,703,547 102%
Injection safety support (INS) $12,630,270 $12,630,270 $12,610,218 100%
IPV (NVS) $28,432,078 $28,432,078 $26,368,891 93%
Measles SIA (NVS) $22,491,870 $22,491,870 $22,604,288 100%
Measles SIA - Operational costs (OPC) $39,423,500 $39,423,500 $39,423,500 100%
Measles-Follow-up campaign (NVS) $10,739,500 $10,739,500 $6,784,125 63%
Measles-Follow-up campaign op.costs (OPC) $14,955,271 $14,955,271 $10,347,671 69%
Meningitis A (NVS) $4,863,000 $14,040,500
Meningitis A - campaign (NVS) $55,966,777 $55,966,777 $56,057,711 100%
Meningitis A - operational costs (OPC) $43,505,648 $43,505,648 $43,505,648 100%
Penta (NVS) $149,981,711 $189,536,711 $140,062,198 93%
Pneumo (NVS) $192,832,878 $322,573,378 $208,336,446 108%
Rotavirus (NVS) $50,788,000 N/A
Vaccine Introduction Grant (VIG) $15,861,921 $15,861,921 $14,176,839 89%
Yellow Fever (NVS) $39,012,946 $39,012,946 $39,711,793 102%
Yellow Fever - campaign (NVS) $32,627,883 $32,627,883 $14,379,693 44%
YF - Operational costs (OPC) $18,571,500 $18,571,500 $6,495,000 35%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nigeria DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 45%
M:F sex ratio at birth (2017) 1.06
Household survey: DTP3 coverage for male (2012) 39.40%
Household survey: DTP3 coverage for female (2012) 37.00%
Household survey: Last DTP3 survey (2012) 38%
% districts achieving > 80% DTP3 coverage (2016) 69%
% districts achieving < 50% DTP3 coverage (2016) 6%
MCV WHO/UNICEF estimates (2016) 51%

Breakdown of support

Non-vaccine support Vaccine support
29% 71%
$214,121,634 $518,008,692

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nigeria

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

30 November 2017

Gavi Board Dec 2017 - Nasala village visit

Millions of children set to be protected against typhoid fever

Gavi Board approves US$ 85 million funding window for 2019-2020 to support the introduction of typhoid conjugate vaccine in developing countries.

close icon

modal window here